Lancet
The most recent articles from:
Lancet
-
Multicenter Study Comparative Study
Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.
Intravenous alteplase is approved for use within 3 h of ischaemic stroke onset, although a meta-analysis of randomised controlled trials suggests treatment benefit up to 4.5 h. We compared outcome in patients treated between 3 h and 4.5 h versus those treated within 3 h, who were recorded in the in the Safe Implementation of Treatments in Stroke (SITS), a prospective internet-based audit of the International Stroke Thrombolysis Registry (ISTR). ⋯ Boehringer-Ingelheim, European Union Public Health Executive Authority.
-
Biography Historical Article
Richard Deckelbaum: building bridges to better health. Interview by Anne Harding.